Cargando…
Commentary: Engineering antibody therapies may be the future of therapeutics
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by The American Association for Thoracic Surgery
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319912/ https://www.ncbi.nlm.nih.gov/pubmed/32680639 http://dx.doi.org/10.1016/j.jtcvs.2020.06.041 |
| _version_ | 1783551136943308800 |
|---|---|
| author | Akhmerov, Akbarshakh Ramzy, Danny |
| author_facet | Akhmerov, Akbarshakh Ramzy, Danny |
| author_sort | Akhmerov, Akbarshakh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7319912 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | by The American Association for Thoracic Surgery |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73199122020-06-29 Commentary: Engineering antibody therapies may be the future of therapeutics Akhmerov, Akbarshakh Ramzy, Danny J Thorac Cardiovasc Surg Commentary by The American Association for Thoracic Surgery 2021-04 2020-06-27 /pmc/articles/PMC7319912/ /pubmed/32680639 http://dx.doi.org/10.1016/j.jtcvs.2020.06.041 Text en © 2020 by The American Association for Thoracic Surgery. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Akhmerov, Akbarshakh Ramzy, Danny Commentary: Engineering antibody therapies may be the future of therapeutics |
| title | Commentary: Engineering antibody therapies may be the future of therapeutics |
| title_full | Commentary: Engineering antibody therapies may be the future of therapeutics |
| title_fullStr | Commentary: Engineering antibody therapies may be the future of therapeutics |
| title_full_unstemmed | Commentary: Engineering antibody therapies may be the future of therapeutics |
| title_short | Commentary: Engineering antibody therapies may be the future of therapeutics |
| title_sort | commentary: engineering antibody therapies may be the future of therapeutics |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319912/ https://www.ncbi.nlm.nih.gov/pubmed/32680639 http://dx.doi.org/10.1016/j.jtcvs.2020.06.041 |
| work_keys_str_mv | AT akhmerovakbarshakh commentaryengineeringantibodytherapiesmaybethefutureoftherapeutics AT ramzydanny commentaryengineeringantibodytherapiesmaybethefutureoftherapeutics |